Amwins launches clinical trials insurance product
Amwins has launched an exclusive clinical trials insurance product through its Brokerage division, offering $25 million limits on paper pre-licensed in more than 115 countries.
The product was developed with an unnamed Lloyd’s syndicate and is available exclusively through Amwins brokers. Coverage includes clinical trials indemnity, no-fault compensation, clinical testing liability, public and products liability, professional liability and medical malpractice.
Eligible risks include sponsors conducting Phase I through Phase IV research, contract research organizations, investigator-led studies and university clinical trial programs. The product has no class limitations and offers same-day quotes, certificates and policy documents.
The international licensing is designed to reduce the need for sponsors to arrange separate local policies in countries where their trials take place.
